Newswise — Chulalongkorn University organized an international academic conference titled “Cutting-edge Nanotechnologies for Good Health and Well-being” to present nanotechnology innovations as new alternatives for cancer treatment. The conference was held from July 9 to 12, 2024, at the Music Hall, Art and Culture Building, Chulalongkorn University, and the Mandarin Hotel, Bangkok. A major problem in cancer treatment is the side effects from chemotherapy.
The medical industry has been trying to find cancer treatments that are highly effective but with lower side effects. Among the current medical advancements, besides CAR-T cell therapy, the latest research involves treating cancer using targeted nanotechnology combined with photodynamic therapy. This is being studied under the “OXIGENATED ” research project, funded by the Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange (H 2020-MSCA-RISE) .
The research was presented at this conference. The OXIGENATED research project is a study on cancer treatment using nanoparticles to deliver oxygen to cancer cells and stimulate the killing of cancer cells with photodynamic therapy. Asst.
Prof. Dr. Chanchai Boonla, Department of Biochemistry, Faculty of Medicine , Chulalongkorn University , is the head of this project, which received funding to conduct research from 2019-2024.
The new treatment is a targeted elimination of cancer cells, which greatly helps reduce the chances of side eff.